The FDA has reassigned the director of its Office of Nonprescription Drugs to a medical devices leadership role, highlighting a strategic shift toward affordability and regulatory realignment. This change may impact drug approval policies and insurance regulatory compliance.

Explore the challenges and regulatory responses shaping California's property insurance market amid wildfire risks and rising reinsurance costs, highlighting insurer withdrawals and evolving consumer protections.

Healthcare premiums in the ACA marketplace may rise significantly in 2026 if current subsidies expire, impacting hundreds of thousands of insured individuals. Learn about subsidy impacts, premium increases, and market implications.

Zing Health sues HHS and CMS over improper Medicare Part D termination and star rating methodology disputes, claiming significant financial and reputational damages.

Access expert insights and detailed coverage of key insurance industry issues to support informed decisions in the U.S. market. Explore regulatory, compliance, and market developments shaping the sector.

Novo Nordisk's semaglutide drugs face significant Medicare price reductions under CMS negotiation rules starting 2027, but new indications could drive future revenue growth.

Ohio man indicted for hit-and-run causing death of teen cyclist; charged with driving without insurance and failure to stop.

Louisiana's auto insurance rates are starting to decline after years of increases, with multiple insurers filing significant rate reductions. Competitive market forces and ongoing reforms may bring further relief to policyholders statewide in 2026.

Geisinger Health System hosts 2026 Medicare Advantage plan seminars for eligible seniors before the December 7 enrollment deadline, highlighting plan benefits and CMS ratings.

C-SPAN.org supports its operations through affiliate revenue from linked book purchases and offers MyC-SPAN users free monthly Congressional hearing downloads, providing key insights into its funding and user features.